Hospital Acquired Pneumonia Pipeline Review – H1 2020 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Hospital Acquired Pneumonia (HAP) – Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. Summary…
Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Hospital Acquired Pneumonia (HAP) – Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. Summary…
DUBLIN–(BUSINESS WIRE)–The “Chemotherapy Induced Nausea and Vomiting – Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering.…
Products within the SigNature® and CertainT® Brand Certified in Strict Compliance with OU Standards as Ingredients for Dietary Supplements, Pharmaceuticals…
WILMINGTON, N.C.–(BUSINESS WIRE)–PPD, Inc. (Nasdaq:PPD), a leading global contract research organization, today announced it will release its fourth quarter and…
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA™ (NYSE: IQV), a leader in human data science, today announced the launch…
— Additional data from Phase 2 study show that MGTA-456 demonstrates clinically meaningful durable benefits for patients with inherited metabolic…
SAN DIEGO–(BUSINESS WIRE)–Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and…
GAINESVILLE, Fla.–(BUSINESS WIRE)–Cyclo Therapeutics, Inc. (OTCQB: CTDH), a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick…
CARLSBAD, Calif.–(BUSINESS WIRE)–$LCTX #AMD—Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies…
Study reports on the first human cellular and metabolomics-based test for the evaluation of drugs for cardiotoxic effects MADISON, Wis.–(BUSINESS…